Allicin inhibits kidney stone formation by suppressing the TNF/NF-κB pathway: Experimental validation through network pharmacology, in vitro, and in vivo studies

Zechun Peng, Mingbin Xu, Jie Yang, Shuming He · 2026

Read Allicin inhibits kidney stone formation by suppressing the TNF/NF-κB pathway: Experimental validation through network pharmacology, in vitro, and in vivo studies by Zechun Peng, Mingbin Xu, Jie Yang, Shuming He (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13253885.txt.

Description

Zechun Peng and colleagues test allicin, a compound from garlic, against kidney stones in a 2026 study. Kidney stones are common and often return. The team combined computer-based target hunting, cell tests on harmed kidney cells, and a rat model where stones were induced with a chemical.

Computer screening found 46 shared targets between allicin and stone disease, with TNF as the central one. In cells, allicin raised survival and cut inflammatory factors. In rats, it reduced kidney damage and calcium oxalate deposits. The authors say it works by blocking the TNF/NF-κB pathway, a chain of signals that drives swelling.

Catalog record

CREATORZechun Peng, Mingbin Xu, Jie Yang, Shuming He
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34797
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13253885

Browse the full library · About the Tower of Babel